New treatments for alopecia areata

The Disease Burden of Generalized Pustular Psoriasis: Real-World Evidence From CorEvitas' Psoriasis Registry.

Journal of psoriasis and psoriatic arthritis·2024

Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase-III trials and the real-life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis.

The British journal of dermatology·2021

Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow-up.

The British journal of dermatology·2021

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Amount and Burden of Brain Tissue Hypoxia to Determine Clinical Efficacy of Secondary Decompressive Craniectomy After Moderate/Severe Traumatic Brain Injury.

Neurosurgery·2026

The effects of epicatechin on oxidative stress and genotoxicity induced by cypermethrin in PC-12 cell line.

Drug and chemical toxicology·2026

Contemporary Treatment Patterns in Surgically Treated Temporal Bone Cancer.

The Laryngoscope·2026

Radiotherapy and immunotherapy in cancer treatment: mechanisms of clinical synergy.

The Journal of clinical investigation·2026

Cost-effectiveness analysis comparison of etelcalcetide, paricalcitol, and cinacalcet for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.

Expert review of pharmacoeconomics & outcomes research·2026

Robotic radical thymectomy using the Hugo RAS system - a step-by-step right thoracic approach.

Multimedia manual of cardiothoracic surgery : MMCTS·2026

Related Experiment Videos

New treatments for alopecia areata

Related Concept Videos

The Disease Burden of Generalized Pustular Psoriasis: Real-World Evidence From CorEvitas' Psoriasis Registry.

Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase-III trials and the real-life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022.

Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis.

Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis.

Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial.

The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow-up.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Amount and Burden of Brain Tissue Hypoxia to Determine Clinical Efficacy of Secondary Decompressive Craniectomy After Moderate/Severe Traumatic Brain Injury.

The effects of epicatechin on oxidative stress and genotoxicity induced by cypermethrin in PC-12 cell line.

Contemporary Treatment Patterns in Surgically Treated Temporal Bone Cancer.

Radiotherapy and immunotherapy in cancer treatment: mechanisms of clinical synergy.

Cost-effectiveness analysis comparison of etelcalcetide, paricalcitol, and cinacalcet for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.

Robotic radical thymectomy using the Hugo RAS system - a step-by-step right thoracic approach.

Related Experiment Videos

New treatments for alopecia areata

Related Concept Videos

Related Articles